AXT Balansräkning Hälsa
Finansiell hälsa kriterier kontrolleras 3/6
AXT har ett totalt eget kapital på $334.6M och en total skuld på $68.0M vilket ger sin skuldsättningsgrad till 20.3%. Dess totala tillgångar och totala skulder är $433.8M respektive $99.1M.
Viktig information
20.32%
Skuldsättning i förhållande till eget kapital
US$68.00m
Skuld
| Räntetäckningsgrad | n/a |
| Kontanter | US$120.27m |
| Eget kapital | US$334.63m |
| Summa skulder | US$99.12m |
| Totala tillgångar | US$433.75m |
Nya uppdateringar om finansiell hälsa
Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Oct 08
Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Mar 29Is AXT (NASDAQ:AXTI) Using Too Much Debt?
Sep 28Is AXT (NASDAQ:AXTI) A Risky Investment?
Mar 29Recent updates
AXTI: Future InP Substrate Demand Will Outweigh Near Term Export Constraints
Narrative Update on AXT The analyst price target for AXT has moved from $45 to $90, with analysts pointing to higher assumed profit margins, an increased future P/E multiple, and stronger long term InP substrate demand expectations supported by recent capacity and capex plans at major optical and cloud players. Analyst Commentary Recent Street research on AXT highlights a mix of optimism on long term InP substrate demand and some short term caution around export related constraints.
AXTI: Export Permit Limits Will Continue To Restrain InP AI Upside
Analysts have raised AXT's fair value estimate from $28.25 to $30.75, reflecting updated views on higher potential P/E multiples, supported by expected InP growth and recent price target increases from several research firms. Analyst Commentary Recent research gives you a mixed but useful read on how the Street is thinking about AXT, with some focusing on long term InP growth potential and others highlighting nearer term execution risks and regulatory overhangs.AXTI: Export Permit Constraints Will Limit Upside Despite InP Demand Story
AXT's analyst fair value estimate has been raised from $26.00 to $45.00 as analysts factor in expectations for higher revenue, stronger profit margins, and a richer forward P/E multiple supported by rising Street price targets related to InP demand and export permit clarity. Analyst Commentary Recent research on AXT points to a split view, with some caution around near term export permit issues, but also a series of more optimistic calls that connect the story to longer term compound semiconductor demand and valuation support tied to InP exposure.
AXTI: Export Permit Constraints Will Limit Benefit Of InP Demand Optimism
The analyst price target for AXT has increased from $8.50 to $21, with analysts citing stronger InP growth expectations, higher projected profit margins, and a higher assumed future P/E multiple as key supports for the updated valuation framework. Analyst Commentary Recent Street research on AXT reflects a wide spread in price targets, with some analysts using relatively high P/E multiples based on long term InP growth expectations and others taking a more cautious stance as they weigh near term execution risks and policy related constraints.AXTI: InP Export Permit Constraints Will Undermine AI Demand Upside Potential
Narrative Update on AXT The analyst price targets for AXT have moved sharply higher, with recent updates ranging from $21 to $35. Analysts are factoring in higher fair value estimates and stronger InP growth expectations, despite ongoing export permit uncertainty.AXT Rallies On Future Outlook And High Demand From AI Computing
Feb 23AXTI: Neutral Stance Will Reflect Export Permit Risks And Equity Raise
Narrative Update on AXT Price Target Analysts have raised their AXT price target from $9 to $18, citing updated assumptions for higher revenue growth and profit margins, as well as a lower discount rate. At the same time, they have shifted to a Neutral stance following export permit related headwinds in InP substrate shipments.AXTI: Export Permit Constraints And Equity Offering Will Pressure Future Returns
Analysts have raised their price target on AXT to US$18 from US$9, citing valuation after the company adjusted its Q4 revenue outlook due to fewer export permits for InP substrates from the Chinese government. Analyst Commentary Bearish analysts are framing the new US$18 price target as less about improving fundamentals and more about the stock having already run ahead of what they see as reasonable expectations.AXTI: Export Permit Uncertainty Will Constrain Near Term Revenue Outlook
Analysts have lifted their price targets for AXT, with moves such as from US$4.10 to US$7 and from US$9 to US$18, citing changing views on export permit progress, revenue assumptions, and valuation. Analyst Commentary Recent Street research on AXT reflects a mixed backdrop, with some bearish analysts turning more cautious even as price targets move higher.AXTI: Export Permits Will Drive Fragile Near Term Revenue Expectations
Analysts lifted their price target on AXT to $7.00 from $4.10, pointing to updated Q3 revenue assumptions after the company received export permits from China's Ministry of Commerce to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts point to the new export permits as a key reason for revisiting their models, with Q3 revenue assumptions adjusted to reflect the potential contribution from indium phosphide substrate shipments to additional customers.AXT, Inc.'s (NASDAQ:AXTI) 39% Share Price Surge Not Quite Adding Up
Dec 19AXTI: New Export Permits Will Intensify Regulatory And Execution Downside Risks
Analysts have raised their price target on AXT by approximately $2.90 per share to around $7.00, citing improved revenue expectations after the company received new export permits that enable it to resume shipping indium phosphide substrates to additional customers. Analyst Commentary Analysts are updating their models ahead of upcoming quarterly results, reflecting the impact of newly granted export permits on AXT's near term revenue and margin profile.AXTI: Export Permit Reliance Will Heighten Downside Risks Amid Ongoing Uncertainty
Analysts have increased their price target for AXT to $7 from $4.10, citing higher anticipated revenues because the company recently obtained export permits that allow it to ship indium phosphide substrates to additional customers. Analyst Commentary Recent updates from the analyst community reflect a reassessment of AXT's growth prospects and financial outlook following the news about new export permits for indium phosphide substrates.AXTI: Renewed Export Permits Will Influence Recovery Amid Regulatory Risks
Analysts have raised AXT's fair value estimate significantly from $5.70 to $9.50 per share, citing improved revenue assumptions following renewed export permits and a higher price target in recent research updates. Analyst Commentary Analyst reactions to AXT's recent developments have brought both optimism and caution regarding the company's future prospects and valuation.AXTI: Export Permit Uncertainty Will Challenge Margin Strength Moving Forward
The analyst price target for AXT has increased significantly from $3.82 to $5.70 per share, as analysts cite improved revenue growth expectations and recent export permit approvals as key drivers behind their revised outlook. Analyst Commentary Analyst sentiment regarding AXT has evolved in response to recent company developments, with notable optimism about future growth prospects.AXT, Inc. (NASDAQ:AXTI) Shares Fly 26% But Investors Aren't Buying For Growth
Oct 14Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Oct 08AXT, Inc. (NASDAQ:AXTI) Stock Catapults 33% Though Its Price And Business Still Lag The Industry
Jul 20
Chinese Data Center Demand And Laser Tech Will Open New Markets
Strategic positioning in the Chinese data center market and local sourcing aims to reduce foreign dependency and boost revenue growth.AXT, Inc.'s (NASDAQ:AXTI) 25% Dip In Price Shows Sentiment Is Matching Revenues
Apr 11Here's Why AXT (NASDAQ:AXTI) Can Afford Some Debt
Mar 29AXT, Inc. Reported Improved Q4 Financial Performance But Q1 Outlook Disappoints
Feb 24Revenues Working Against AXT, Inc.'s (NASDAQ:AXTI) Share Price Following 31% Dive
Feb 22Lacklustre Performance Is Driving AXT, Inc.'s (NASDAQ:AXTI) 31% Price Drop
Feb 22Little Excitement Around AXT, Inc.'s (NASDAQ:AXTI) Revenues As Shares Take 30% Pounding
Nov 16AXT, Inc. (NASDAQ:AXTI) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 03AXT, Inc.: Not Getting The Recognition It Deserves
Oct 26Is AXT (NASDAQ:AXTI) Using Too Much Debt?
Sep 28AXT, Inc. (NASDAQ:AXTI) Not Doing Enough For Some Investors As Its Shares Slump 26%
Aug 28AXT, Inc.: Downgrading On Limited Visibility And Early Cracks In The AI Story
Aug 05AXT, Inc. (NASDAQ:AXTI) Analysts Are Pretty Bullish On The Stock After Recent Results
Aug 04AXT Inc.: Playing An Expected Rebound
Jul 21AXT: Strong Outlook As Business Recovery Is Picking Up Steam - Buy
May 07Little Excitement Around AXT, Inc.'s (NASDAQ:AXTI) Revenues As Shares Take 34% Pounding
Apr 06AXT: Selloff Provides Buying Opportunity
Apr 05Is AXT (NASDAQ:AXTI) A Risky Investment?
Mar 29Analys av finansiell ställning
Kortfristiga skulder: AXTI s kortfristiga tillgångar ( $246.6M ) överstiger dess kortfristiga skulder ( $90.5M ).
Långfristiga skulder: AXTI s kortfristiga tillgångar ( $246.6M ) överstiger dess långfristiga skulder ( $8.6M ).
Skuld till eget kapital Historik och analys
Skuldnivå: AXTI har mer kontanter än sin totala skuld.
Minska skulden: AXTI s skuldsättningsgrad har ökat från 4.1% till 20.3% under de senaste 5 åren.
Skuldtäckning: AXTI s operativa kassaflöde är negativt, därför är skulden inte väl täckt.
Räntetäckning: Otillräckliga data för att avgöra om AXTI s räntebetalningar på sin skuld är väl täckt av EBIT.
Balansräkning
Upptäck friska företag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/04/30 09:52 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2025/12/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
AXT, Inc. bevakas av 7 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Ku Kang | B. Riley Securities, Inc. |
| Hamed Khorsand | BWS Financial Inc. |
| Richard Shannon | Craig-Hallum Capital Group LLC |